Total medical devices industry cross border M&A deals worth $472.5m were announced globally in February 2022, led by Dreamtech’s $227.57m acquisition of 9.1% stake in Cardiac Insight, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 20.3% over the previous month of $592.62m and a drop of 71.5% when compared with the last 12-month average, which stood at $1.66bn.
Comparing cross border M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $261.57m. At the country level, the US topped the list in terms of deal value at $261.57m.
In terms of volumes, Europe emerged as the top region for medical devices industry cross border M&A deals globally, followed by North America and then Asia-Pacific.
The top country in terms of cross border M&A deals activity in February 2022 was the US with seven deals, followed by the Denmark with three and Germany with three.
In 2022, as of February, medical devices cross border M&A deals worth $1.07bn were announced globally, marking an increase of 42.8% year on year.
medical devices industry cross border M&A deals in February 2022: Top deals
The top three cross border M&A deals accounted for 99.7% of the overall value during February 2022.
The combined value of the top three medical devices cross border M&A deals stood at $471.52m, against the overall value of $472.5m recorded for the month.
The top three medical devices industry cross border M&A deals of February 2022 tracked by GlobalData were:
1) Dreamtech $227.57m acquisition deal for 9.1% stake in Cardiac Insight
2) The $210m private equity deal with Micro Life Sciences by South Elm Investments B V
3) Fagron $34m acquisition deal with Letco Medical